Rutherford Health plc is at the vanguard of advancing cancer care in the UK and internationally, building a network of oncology centres known as the Rutherford Cancer Centres.
The centres have been named to reflect the renowned scientist Ernest Rutherford’s contribution to the identification (1909-1919) and naming of the proton in 1920.
Rutherford Health plc has partnered with leading providers to equip each centre with the very latest cancer technology, including IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions, Elekta, a leading provider of radiotherapy treatments, and Philips, a leader in health technology.
The company plans to open further centres over the next few years and its first centre in South Wales was the first in the UK to offer and treat with high energy proton beam therapy.
The company was founded in 2015 by Mike Moran and UK and international cancer experts, including Professor Edward Karol Sikora, former head of the World Health Organisation’s cancer programme.
Initial investors include the Wales Life Sciences Investment Fund and the Woodford Patient Capital Trust.